Abbott Medical Devices

Quick facts

Marketed products

• clopidogrel + aspirin OR prasugrel + aspirin · Cardiovascular
  This dual antiplatelet therapy combines two P2Y12 inhibitors (clopidogrel or prasugrel) with aspirin to prevent blood clots by blocking platelet aggregation through different pathways.

Phase 1 pipeline

• Non-Vitamin K Oral Antagonists

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Abbott Medical Devices portfolio CI brief
• Abbott Medical Devices pipeline updates RSS